Works matching AU Inoue, Y.


Results: 382
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.

    Published in:
    Journal of Viral Hepatitis, 2010, v. 17, n. 5, p. 336, doi. 10.1111/j.1365-2893.2009.01182.x
    By:
    • Inoue, Y.;
    • Hiramatsu, N.;
    • Oze, T.;
    • Yakushijin, T.;
    • Mochizuki, K.;
    • Hagiwara, H.;
    • Oshita, M.;
    • Mita, E.;
    • Fukui, H.;
    • Inada, M.;
    • Tamura, S.;
    • Yoshihara, H.;
    • Hayashi, E.;
    • Inoue, A.;
    • Imai, Y.;
    • Kato, M.;
    • Miyagi, T.;
    • Hohsui, A.;
    • Ishida, H.;
    • Kiso, S.
    Publication type:
    Article
    22

    Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.

    Published in:
    Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 586, doi. 10.1111/j.1365-2893.2009.01106.x
    By:
    • Hiramatsu, N.;
    • Oze, T.;
    • Yakushijin, T.;
    • Inoue, Y.;
    • Igura, T.;
    • Mochizuki, K.;
    • Imanaka, K.;
    • Kaneko, A.;
    • Oshita, M.;
    • Hagiwara, H.;
    • Mita, E.;
    • Nagase, T.;
    • Ito, T.;
    • Inui, Y.;
    • Hijioka, T.;
    • Katayama, K.;
    • Tamura, S.;
    • Yoshihara, H.;
    • Imai, Y.;
    • Kato, M.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    45
    46
    47
    48
    49
    50